Dr. Eulo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UAB Hospital
1802 Sixth Ave S
Birmingham, AL 35233Phone+1 205-801-9304
Summary
- Vanessa Eulo, MD is an oncologist located in Birmingham, AL with a subspecialty in sarcoma. She graduated from Rush Medical College of Rush University Medical Center in 2015 and went on to complete a residency in Internal Medicine and a fellowship in Hematology and Oncology at Washington University/B-JH/SLCH Consortium. Dr. Eulo has experience in treating soft tissue sarcomas, malignant bone tumors and sarcomas, and is also involved in clinical research. She has multiple publications, many of which have been cited by other publications, and has been involved in several clinical trials. Dr. Eulo is an inductee of the Alpha Omega Alpha Honor Medical Society.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2018 - 2021- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2015 - 2018
Rush Medical College of Rush University Medical CenterClass of 2015
Certifications & Licensure
AL State Medical License 2021 - 2024
MO State Medical License 2018 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Clinical Trials
- A Study of AL102 in Patients With Progressing Desmoid Tumors Start of enrollment: 2021 Mar 30
- (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors Start of enrollment: 2022 Apr 14
Publications & Presentations
PubMed
- 18 citationsGenomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.Isidro Cortes-Ciriano, Christopher D Steele, Katherine Piculell, Alyaa Al-Ibraheemi, Vanessa Eulo
Cancer Discovery. 2023-03-01 - 3 citationsRacial and ethnic variation in presentation and outcomes of high-grade soft tissue sarcoma at a Southeastern United States comprehensive cancer center.Ann Carol Braswell, Victoria Jiminez, Kelsey B Montgomery, M Chandler McLeod, Kristy K Broman
American Journal of Surgery. 2024-01-01 - 1 citationsContemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.Angela C Hirbe, Carina A Dehner, Eva Dombi, Vanessa Eulo, Andrea M Gross
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
